Centene Q3 2026 earnings: swings to profit as medical costs ease, guidance raised
Centene topped Wall Street's very low profit bar and raised its full-year outlook as medical costs ran better than planned.
| Q3 2026 | Reported | Expected | Surprise |
|---|---|---|---|
| EPS | $0.58 | $0.10 | +490.6% |
| Revenue | $50.65B | $47.59B | +6.4% |
Key takeaways
- Centene’s results came in far above what analysts had modeled, as costs from paying out medical claims ran lower than the company itself had expected going into the quarter.
- Revenue grew at a strong double-digit pace from a year earlier and cleared analyst estimates, showing the business kept expanding even as it worked through a difficult stretch over the past year.
- The improvement centered on Centene’s Medicare business, which performed better than planned; management said its Medicaid and Marketplace (ACA exchange) businesses tracked in line with expectations.
- The company raised its full-year 2026 profit guidance, now calling for adjusted earnings per share above $5.20 (up 40 cents from its previous outlook) and GAAP earnings per share above $3.46.
- Centene also said it cut debt by $1.1 billion since mid-2026, a sign the business is generating more cash to pay down borrowings after a rough patch.
- CEO Sarah London attributed the stronger-than-expected results to solid underlying fundamentals across the company’s core insurance businesses, calling it a faster recovery in earnings than the company had anticipated.
- Trailing-twelve-month profitability measures — operating margin, net margin and return on equity — are still negative, a reminder that a large loss booked earlier in this stretch continues to drag down the full-year picture even as the most recent quarter improved.
- Coverage framed the quarter as a turnaround moment, noting the company had been expected to post only a marginal profit and instead delivered a much larger beat, which drove a sharp rise in the stock.
How the stock took it
Centene Corp closed at $68.03 on Oct 26, 2026, the last session before the report, and at $67.05 on Oct 28, 2026, the first session after it — -1.4% across the report.
Closes from the market's daily record. Each figure spans the report date — from the last session that closed before it to the first that closed after — because a company may report before the open or after the close.
Fundamentals
| Metric | Value | Period |
|---|---|---|
| Gross margin | 7.2% | Trailing 12 months |
| Operating margin | -3.7% | Trailing 12 months |
| Net profit margin | -3.3% | Trailing 12 months |
| Pretax margin | -3.2% | Trailing 12 months |
| EPS | -$10.44 | Trailing 12 months |
| Revenue growth (YoY) | 17.0% | Trailing 12 months |
| Return on equity | -24.0% | Trailing 12 months |
Sources: company report · Stocktwits